Conte Lab Awarded Multiple Grants to Develop Drug-Device Preventing Restenosis in Cardiovascular Patients
UCSF Division of Vascular & Endovascular Surgery - - May 03, 2017
Michael S. Conte, M.D., Professor and Chief of the Division of Vascular & Endovascular Surgery and Director of the Conte Lab, has been awarded two grants to develop a prototype medical device that will deliver bioactive lipid mediators to prevent "restenosis", the recurrent narrowing of blood vessels following interventions such as angioplasty, stenting, and bypass surgery. The bioactive compounds are being developed in the Conte Lab.
The first grant, a $200.000 Technology Development Award from the UC Center for Accelerated Innovation, is funded through a combination of grants and [...]